Investment
Features
FeesSafety
Academy
More
Pluang+

Urban Outfitters gets 'Buy' rating from Needham with positive earnings outlook and rising stock price.

Analyst Insights
16 Oct 2026
Alex Lavoie
View Source
Bullish
Urban Outfitters gets 'Buy' rating from Needham with positive earnings outlook and rising stock price.

Investment firm Needham initiated coverage on Urban Outfitters with a 'Buy' rating, reflecting optimism about the retail company's future performance. Urban Outfitters, which owns brands like Anthropologie and Free People, currently trades at $87.40 with a market cap of about $7.49 billion. The stock has recently appreciated, signaling potential value for investors. This rating suggests analysts expect Urban Outfitters to outperform, supported by a favorable earnings outlook compared to peers like Ermenegildo Zegna.

Urban Outfitters receives a Needham Buy rating. For readers following consumer cyclical stocks, here is Pluang's market snapshot as of Oct 16, 2026 20:42 WIB: 105 of 134 US consumer cyclical stocks rose today. Notable movers include Dicks Sporting Goods at USD 145.08 (+3.01%, 96% Buy), Gogoro Inc at USD 3.23 (+2.87%, 96% Sell), and CarMax at USD 54.09 (+2.79%, 100% Buy).

More News

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...

Market News
Bullish
36 minutes ago
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

Market News
Neutral
1 hour ago
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
1 hour ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App